With ANDA reporting through January 21, 2022, the OGD has issued thirty full‑approval actions and eight tentative‑approval actions for a total of thirty‑eight approval actions issued so far this month. With only six more reporting days remaining, these unofficial numbers, gathered from the FDA All Approvals list here, it looks like the total approval actions for the month will be somewhere in the upper 40s or low 50s if the pace of approvals picks up over the remainder of the month.
Not much good news over the last few months so we’re hopeful that the approval pace will pick up in the next couple of months.
